Is Acusphere Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Acusphere Inc (ACUS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Acusphere Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Acusphere Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Acusphere Inc?

Muslim investors may consider investing in Acusphere Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Acusphere Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Acusphere Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Acusphere Inc updated?

The Shariah compliance status of Acusphere Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Acusphere Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Acusphere Inc?

You can check the latest Shariah compliance status of Acusphere Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Acusphere Inc. Stock Analysis ACUS

United States Health Care Nano Cap

Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).

Financial Metrics & Statements of Acusphere Inc (ACUS)

FAQ's for Acusphere Inc (ACUS)

According to Musaffa’s Shariah screening methodology, Acusphere Inc (ACUS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.